HALO logo
halo search icon
Amylyx Pharmaceuticals, Inc.

US$13.61

Price Change Indicator
0.87 (6.83%)
Amylyx Pharmaceuticals, Inc.
AMLX · NAS

Amylyx Pharmaceuticals, Inc.

Start Trading AMLX for Free

US$13.61

Price Arrow0.87 (6.83%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownExtreme OversoldHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Amylyx Pharmaceuticals, Inc. Overview

AMLX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AMLX

icon

Website

Amylyx Pharmaceuticals, Inc.

icon

Telephone

1.617.682.0917

icon

Address

Suite 6W, 55 Cambridge Parkway, Cambridge, MA 02142

Description

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

AMLX Price Chart

Key Stats

Market Cap

US$1.42B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.64 - 18.6

Trade Value (12mth)

US$4,377,548.00

1 week

-4.1%

1 month

-27.57%

YTD

11.56%

1 year

134.62%

All time high

41.93

Key Fundamentals

EPS 3 yr Growth

-48.70%

EBITDA Margin

0.00%

Operating Cashflow

-$123m

Free Cash Flow Return

-51.90%

ROIC

-60.90%

Interest Coverage

0.00

Quick Ratio

14.30

Other Data

Shares Outstanding (Fully Diluted)

111m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AMLX Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
24 March 26
03 March 26

AMLX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.73-4.43-1.53locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.7-4.43-1.53locklocklock
Growth
 %locklocklocklock124.6-704.365.4locklocklock
PE
 Xlocklocklocklock20.93.9N/Alocklocklock
EV/EBITDA
 Xlocklocklocklock16.71.1N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Amylyx Pharmaceuticals, Inc. (AMLX:NAS)?
Halo FAQ
The current share price of Amylyx Pharmaceuticals, Inc. (AMLX:NAS) is USD$13.61.
What is the 52-week high share price for Amylyx Pharmaceuticals, Inc. (AMLX:NAS)?
Halo FAQ
The 52-week high share price for Amylyx Pharmaceuticals, Inc. (AMLX:NAS) is USD$18.60.
What is the 52-week low share price for Amylyx Pharmaceuticals, Inc. (AMLX:NAS)?
Halo FAQ
The 52-week low share price for Amylyx Pharmaceuticals, Inc. (AMLX:NAS) is USD$4.64.
What is the dividend yield for Amylyx Pharmaceuticals, Inc. (AMLX:NAS)?
Halo FAQ
Amylyx Pharmaceuticals, Inc. (AMLX:NAS) does not pay a dividend.
What was Amylyx Pharmaceuticals, Inc. (AMLX:NAS) last dividend payment?
Halo FAQ
Amylyx Pharmaceuticals, Inc. (AMLX:NAS) does not pay a dividend.
What is the franking level for Amylyx Pharmaceuticals, Inc. (AMLX:NAS)?
Halo FAQ
Amylyx Pharmaceuticals, Inc. (AMLX:NAS) has a franking level of 0.00%.
In which sector is Amylyx Pharmaceuticals, Inc. (AMLX:NAS) classified?
Halo FAQ
Amylyx Pharmaceuticals, Inc. (AMLX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial